News | June 10, 2026
GSK bets big on oncology with $10.6 billion Nuvalent acquisition
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology
Donor families honoured as Apollo highlights over 27,500 transplants performed and calls for greater public participation in organ donation
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
The facility sets a new benchmark in respiratory diagnostics
Initiatives at Churchgate Station and Mahindra & Mahindra focus on early detection, public education, and tobacco-related cancer prevention
The conference highlighted research suggesting that deuterium levels may influence key biological processes
The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy
The company said the breadth of its showcase reflects “progress from its differentiated oncology pipeline in solid tumors and hematologic malignancies,”
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
